Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: Outcomes from the pulmonary hypertension assessment and recognition of outcomes in Scleroderma registry

Arthritis Care and Research

Volumn 66, Issue 3, 2014, Pages 489-495

  Chung, Lorinda ^a,b   Domsic, Robyn T ^c   Lingala, Bharathi ^a   Alkassab, Firas ^d   Bolster, Marcy ^e   Csuka, M E ^f   Derk, Chris ^g   Fischer, Aryeh ^h   Frech, Tracy ⁱ   Furst, Daniel E ^j   Gomberg Maitland, Mardi ^k   Hinchcliff, Monique ^l   Hsu, Vivien ^m   Hummers, Laura K ⁿ   Khanna, Dinesh ^o   Medsger Jr , Thomas A ^c   Molitor, Jerry A ^p   Preston, Ioana R ^q   Schiopu, Elena ^o   Shapiro, Lee ^r   Silver, Richard ^e   Simms, Robert ^e   Varga, John ^s   Gordon, Jessica K ^t   Steen, Virginia D ^u   more..

^a STANFORD UNIVERSITY   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF MASSACHUSETTS   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h DEPARTMENT OF MEDICINE   (United States)

ⁱ UNIVERSITY OF UTAH   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k UNIVERSITY OF CHICAGO   (United States)

^l NORTHWESTERN UNIVERSITY   (United States)

^m UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

ⁿ JOHNS HOPKINS UNIVERSITY   (United States)

^o UNIVERSITY OF MICHIGAN   (United States)

^p UNIVERSITY OF MINNESOTA   (United States)

^q TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r Center for Rheumatology LLP   (United States)

^s BOSTON UNIVERSITY   (United States)

^t HOSPITAL FOR SPECIAL SURGERY   (United States)

^u GEORGETOWN UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARBON MONOXIDE; CENTROMERE ANTIBODY; CREATININE; ENDOTHELIN RECEPTOR ANTAGONIST; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN DERIVATIVE; RIBONUCLEOPROTEIN ANTIBODY; SCL 70 ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; DISEASE DURATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; FORCED VITAL CAPACITY; HEART CATHETERIZATION; HIGH RISK PATIENT; HUMAN; INCIDENCE; LONGITUDINAL STUDY; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PROSPECTIVE STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; REGISTER; SCREENING; SURVIVAL RATE; SYSTEMIC SCLEROSIS;

AGED; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; SCLERODERMA, SYSTEMIC; UNITED STATES;

EID: 84896692199     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22121     Document Type: Article

References (15)

1. Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003; 62: 1088-93.
2. Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52: 3792-800.
3. Hesselstrand R, Wildt M, Ekmehag B, Wuttge DM, Scheja A,. Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult. Scand J Rheumatol 2011; 40: 127-32.
4. Komocsi A, Vorobcsuk A, Faludi R, Pinter T, Lenkey Z, Kolto G, et al. The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies. Rheumatology (Oxford) 2012; 51: 1027-36.
5. Chung L, Liu J, Parsons L, Hassoun PM, McGoon M, Badesch DB, et al. Characterization of connective tissue disease associated pulmonary arterial hypertension from the REVEAL registry: identifying systemic sclerosis as a unique phenotype. Chest 2010; 138: 1383-94.
6. Williams MH, Das C, Handler CE, Akram MR, Davar J, Denton CP, et al. Systemic sclerosis associated pulmonary hypertension: improved survival in the current era. Heart 2006; 92: 926-32.
7. Campo A, Mathai SC, Le Pavec J, Zaiman AL, Hummers LK, Boyce D, et al. Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension. Am J Respir Crit Care Med 2010; 182: 252-60.
8. Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, et al. Connective tissue disease associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009; 179: 151-7.
9. Galie N, Rubin L, Hoeper M, Jansa P, Al-Hiti H, Meyer G, et al. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet 2008; 371: 2093-100.
10. Hachulla E, Launay D, Yaici A, Berezne A, de Groote P, Sitbon O, et al. Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome. Rheumatology (Oxford) 2010; 49: 940-4.
11. Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum 2011; 63: 3522-30.
12. Fischer A, Bull TM, Steen VD,. Practical approach to screening for scleroderma-associated pulmonary arterial hypertension. Arthritis Care Res (Hoboken) 2012; 64: 303-10.
13. Hinchcliff M, Fischer A, Schiopu E, Steen VD,. Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population. J Rheumatol 2011; 38: 2172-9.
14. Ngian GS, Stevens W, Prior D, Gabbay E, Roddy J, Tran A, et al. Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study. Arthritis Res Ther 2012; 14: R213.
15. Chandra S, Shah SJ, Thenappan T, Archer SL, Rich S, Gomberg-Maitland M,. Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension. J Heart Lung Transplant 2010; 29: 181-7.